Intrinsic value of Rite Aid - RAD

Previous Close

$2.28

  Intrinsic Value

$3.51

stock screener

  Rating & Target

str. buy

+54%

  Value-price divergence*

-34%

Previous close

$2.28

 
Intrinsic value

$3.51

 
Up/down potential

+54%

 
Rating

str. buy

 
Value-price divergence*

-34%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of RAD stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 2.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2017(a)
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  6.86
  6.90
  6.71
  6.54
  6.39
  6.25
  6.12
  6.01
  5.91
  5.82
  5.74
  5.66
  5.60
  5.54
  5.48
  5.43
  5.39
  5.35
  5.32
  5.29
  5.26
  5.23
  5.21
  5.19
  5.17
  5.15
  5.14
  5.12
  5.11
  5.10
  5.09
Revenue, $m
  32,845
  35,111
  37,467
  39,917
  42,466
  45,119
  47,881
  50,758
  53,758
  56,885
  60,148
  63,554
  67,111
  70,826
  74,710
  78,770
  83,016
  87,460
  92,110
  96,978
  102,076
  107,415
  113,009
  118,871
  125,015
  131,455
  138,207
  145,287
  152,712
  160,500
  168,668
Variable operating expenses, $m
 
  34,257
  36,544
  38,922
  41,397
  43,972
  46,653
  49,447
  52,358
  55,394
  58,562
  61,697
  65,150
  68,757
  72,526
  76,468
  80,591
  84,904
  89,418
  94,144
  99,093
  104,276
  109,707
  115,398
  121,362
  127,614
  134,169
  141,042
  148,250
  155,809
  163,739
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  32,369
  34,257
  36,544
  38,922
  41,397
  43,972
  46,653
  49,447
  52,358
  55,394
  58,562
  61,697
  65,150
  68,757
  72,526
  76,468
  80,591
  84,904
  89,418
  94,144
  99,093
  104,276
  109,707
  115,398
  121,362
  127,614
  134,169
  141,042
  148,250
  155,809
  163,739
Operating income, $m
  476
  855
  923
  995
  1,069
  1,147
  1,228
  1,312
  1,399
  1,491
  1,586
  1,857
  1,961
  2,070
  2,183
  2,302
  2,426
  2,556
  2,692
  2,834
  2,983
  3,139
  3,302
  3,474
  3,653
  3,841
  4,039
  4,246
  4,462
  4,690
  4,929
EBITDA, $m
  1,044
  1,367
  1,458
  1,554
  1,653
  1,756
  1,864
  1,976
  2,092
  2,214
  2,341
  2,474
  2,612
  2,757
  2,908
  3,066
  3,231
  3,404
  3,585
  3,775
  3,973
  4,181
  4,398
  4,627
  4,866
  5,116
  5,379
  5,655
  5,944
  6,247
  6,565
Interest expense (income), $m
  410
  418
  428
  470
  515
  561
  609
  659
  711
  765
  822
  881
  943
  1,007
  1,074
  1,145
  1,218
  1,295
  1,376
  1,460
  1,548
  1,640
  1,737
  1,838
  1,944
  2,056
  2,172
  2,295
  2,423
  2,557
  2,698
Earnings before tax, $m
  48
  437
  496
  525
  555
  586
  619
  653
  688
  725
  764
  976
  1,018
  1,063
  1,109
  1,157
  1,208
  1,261
  1,316
  1,374
  1,435
  1,499
  1,565
  1,635
  1,709
  1,786
  1,866
  1,951
  2,040
  2,133
  2,231
Tax expense, $m
  44
  118
  134
  142
  150
  158
  167
  176
  186
  196
  206
  264
  275
  287
  299
  312
  326
  340
  355
  371
  387
  405
  423
  442
  461
  482
  504
  527
  551
  576
  602
Net income, $m
  4
  319
  362
  383
  405
  428
  452
  477
  502
  530
  558
  713
  743
  776
  809
  845
  882
  920
  961
  1,003
  1,047
  1,094
  1,143
  1,194
  1,247
  1,304
  1,362
  1,424
  1,489
  1,557
  1,628

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  245
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  11,594
  12,394
  13,225
  14,090
  14,990
  15,926
  16,901
  17,917
  18,975
  20,079
  21,231
  22,433
  23,689
  25,000
  26,371
  27,804
  29,303
  30,872
  32,513
  34,231
  36,031
  37,916
  39,890
  41,959
  44,128
  46,401
  48,785
  51,284
  53,905
  56,654
  59,537
Adjusted assets (=assets-cash), $m
  11,349
  12,394
  13,225
  14,090
  14,990
  15,926
  16,901
  17,917
  18,975
  20,079
  21,231
  22,433
  23,689
  25,000
  26,371
  27,804
  29,303
  30,872
  32,513
  34,231
  36,031
  37,916
  39,890
  41,959
  44,128
  46,401
  48,785
  51,284
  53,905
  56,654
  59,537
Revenue / Adjusted assets
  2.894
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
  2.833
Average production assets, $m
  3,174
  3,406
  3,634
  3,872
  4,119
  4,377
  4,644
  4,924
  5,214
  5,518
  5,834
  6,165
  6,510
  6,870
  7,247
  7,641
  8,053
  8,484
  8,935
  9,407
  9,901
  10,419
  10,962
  11,531
  12,126
  12,751
  13,406
  14,093
  14,813
  15,568
  16,361
Working capital, $m
  2,060
  1,966
  2,098
  2,235
  2,378
  2,527
  2,681
  2,842
  3,010
  3,186
  3,368
  3,559
  3,758
  3,966
  4,184
  4,411
  4,649
  4,898
  5,158
  5,431
  5,716
  6,015
  6,329
  6,657
  7,001
  7,361
  7,740
  8,136
  8,552
  8,988
  9,445
Total debt, $m
  7,329
  7,503
  8,252
  9,030
  9,840
  10,683
  11,560
  12,474
  13,427
  14,421
  15,457
  16,539
  17,669
  18,849
  20,083
  21,373
  22,722
  24,134
  25,611
  27,157
  28,777
  30,473
  32,250
  34,113
  36,064
  38,110
  40,255
  42,504
  44,863
  47,337
  49,932
Total liabilities, $m
  10,980
  11,154
  11,903
  12,681
  13,491
  14,334
  15,211
  16,125
  17,078
  18,072
  19,108
  20,190
  21,320
  22,500
  23,734
  25,024
  26,373
  27,785
  29,262
  30,808
  32,428
  34,124
  35,901
  37,764
  39,715
  41,761
  43,906
  46,155
  48,514
  50,988
  53,583
Total equity, $m
  614
  1,239
  1,323
  1,409
  1,499
  1,593
  1,690
  1,792
  1,898
  2,008
  2,123
  2,243
  2,369
  2,500
  2,637
  2,780
  2,930
  3,087
  3,251
  3,423
  3,603
  3,792
  3,989
  4,196
  4,413
  4,640
  4,878
  5,128
  5,390
  5,665
  5,954
Total liabilities and equity, $m
  11,594
  12,393
  13,226
  14,090
  14,990
  15,927
  16,901
  17,917
  18,976
  20,080
  21,231
  22,433
  23,689
  25,000
  26,371
  27,804
  29,303
  30,872
  32,513
  34,231
  36,031
  37,916
  39,890
  41,960
  44,128
  46,401
  48,784
  51,283
  53,904
  56,653
  59,537
Debt-to-equity ratio
  11.936
  6.050
  6.240
  6.410
  6.560
  6.710
  6.840
  6.960
  7.080
  7.180
  7.280
  7.370
  7.460
  7.540
  7.620
  7.690
  7.750
  7.820
  7.880
  7.930
  7.990
  8.040
  8.080
  8.130
  8.170
  8.210
  8.250
  8.290
  8.320
  8.360
  8.390
Adjusted equity ratio
  0.033
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  4
  319
  362
  383
  405
  428
  452
  477
  502
  530
  558
  713
  743
  776
  809
  845
  882
  920
  961
  1,003
  1,047
  1,094
  1,143
  1,194
  1,247
  1,304
  1,362
  1,424
  1,489
  1,557
  1,628
Depreciation, amort., depletion, $m
  568
  512
  535
  559
  583
  609
  636
  664
  693
  723
  755
  616
  651
  687
  725
  764
  805
  848
  893
  941
  990
  1,042
  1,096
  1,153
  1,213
  1,275
  1,341
  1,409
  1,481
  1,557
  1,636
Funds from operations, $m
  -223
  831
  897
  942
  988
  1,037
  1,088
  1,140
  1,195
  1,253
  1,313
  1,329
  1,394
  1,463
  1,534
  1,609
  1,687
  1,769
  1,854
  1,944
  2,038
  2,136
  2,239
  2,347
  2,460
  2,579
  2,703
  2,833
  2,970
  3,114
  3,264
Change in working capital, $m
  -449
  127
  132
  137
  143
  149
  155
  161
  168
  175
  183
  191
  199
  208
  217
  227
  238
  249
  260
  273
  285
  299
  313
  328
  344
  361
  378
  396
  416
  436
  457
Cash from operations, $m
  226
  704
  765
  804
  846
  888
  933
  979
  1,027
  1,078
  1,130
  1,138
  1,195
  1,255
  1,317
  1,381
  1,449
  1,520
  1,594
  1,671
  1,752
  1,837
  1,926
  2,019
  2,116
  2,218
  2,325
  2,437
  2,555
  2,678
  2,807
Maintenance CAPEX, $m
  0
  -317
  -341
  -363
  -387
  -412
  -438
  -464
  -492
  -521
  -552
  -583
  -616
  -651
  -687
  -725
  -764
  -805
  -848
  -893
  -941
  -990
  -1,042
  -1,096
  -1,153
  -1,213
  -1,275
  -1,341
  -1,409
  -1,481
  -1,557
New CAPEX, $m
  -481
  -232
  -229
  -238
  -247
  -257
  -268
  -279
  -291
  -303
  -317
  -330
  -345
  -360
  -377
  -394
  -412
  -431
  -451
  -472
  -494
  -518
  -543
  -569
  -596
  -625
  -655
  -687
  -720
  -755
  -792
Cash from investing activities, $m
  -464
  -549
  -570
  -601
  -634
  -669
  -706
  -743
  -783
  -824
  -869
  -913
  -961
  -1,011
  -1,064
  -1,119
  -1,176
  -1,236
  -1,299
  -1,365
  -1,435
  -1,508
  -1,585
  -1,665
  -1,749
  -1,838
  -1,930
  -2,028
  -2,129
  -2,236
  -2,349
Free cash flow, $m
  -238
  154
  196
  203
  211
  219
  227
  236
  244
  253
  262
  224
  234
  243
  253
  263
  273
  283
  294
  305
  317
  329
  341
  354
  367
  381
  395
  410
  425
  441
  458
Issuance/(repayment) of debt, $m
  309
  174
  748
  778
  810
  843
  877
  914
  953
  994
  1,037
  1,082
  1,130
  1,180
  1,234
  1,290
  1,349
  1,412
  1,477
  1,547
  1,619
  1,696
  1,777
  1,862
  1,952
  2,046
  2,145
  2,249
  2,359
  2,474
  2,595
Issuance/(repurchase) of shares, $m
  7
  307
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  359
  481
  748
  778
  810
  843
  877
  914
  953
  994
  1,037
  1,082
  1,130
  1,180
  1,234
  1,290
  1,349
  1,412
  1,477
  1,547
  1,619
  1,696
  1,777
  1,862
  1,952
  2,046
  2,145
  2,249
  2,359
  2,474
  2,595
Total cash flow (excl. dividends), $m
  121
  635
  944
  982
  1,021
  1,062
  1,105
  1,150
  1,197
  1,246
  1,298
  1,306
  1,364
  1,424
  1,487
  1,553
  1,622
  1,695
  1,772
  1,852
  1,936
  2,025
  2,118
  2,216
  2,319
  2,427
  2,540
  2,659
  2,784
  2,915
  3,053
Retained Cash Flow (-), $m
  -33
  -625
  -83
  -86
  -90
  -94
  -97
  -102
  -106
  -110
  -115
  -120
  -126
  -131
  -137
  -143
  -150
  -157
  -164
  -172
  -180
  -188
  -197
  -207
  -217
  -227
  -238
  -250
  -262
  -275
  -288
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  10
  861
  895
  931
  968
  1,007
  1,048
  1,091
  1,136
  1,183
  1,186
  1,238
  1,292
  1,349
  1,409
  1,472
  1,538
  1,607
  1,680
  1,756
  1,837
  1,921
  2,009
  2,102
  2,199
  2,302
  2,409
  2,522
  2,640
  2,764
Discount rate, %
 
  13.30
  13.97
  14.66
  15.40
  16.17
  16.97
  17.82
  18.71
  19.65
  20.63
  21.66
  22.75
  23.88
  25.08
  26.33
  27.65
  29.03
  30.48
  32.01
  33.61
  35.29
  37.05
  38.91
  40.85
  42.89
  45.04
  47.29
  49.65
  52.14
  54.74
PV of cash for distribution, $m
 
  9
  663
  594
  525
  458
  393
  333
  277
  226
  181
  137
  106
  80
  59
  42
  30
  20
  13
  9
  5
  3
  2
  1
  1
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7
  88.7

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy Segment sells prescription drugs; and a range of other merchandises, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides health coaching, shared decision making tools, and health care analytics, including health coaching for medical decisions, chronic conditions, and wellness; population analytic solutions; and consulting services. The Pharmacy Services Segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. It also offers integrated mail-order and specialty pharmacy services; and performs prescription adjudication services for other PBMs. Rite Aid Corporation has a strategic alliance with GNC. As of February 27, 2016, the company operated approximately 4,561 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

FINANCIAL RATIOS  of  Rite Aid (RAD)

Valuation Ratios
P/E Ratio 600.6
Price to Sales 0.1
Price to Book 3.9
Price to Tangible Book
Price to Cash Flow 10.6
Price to Free Cash Flow -9.4
Growth Rates
Sales Growth Rate 6.9%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -28.2%
Cap. Spend. - 3 Yr. Gr. Rate 2.7%
Financial Strength
Quick Ratio 12
Current Ratio 0
LT Debt to Equity 1190.2%
Total Debt to Equity 1193.6%
Interest Coverage 1
Management Effectiveness
Return On Assets 0.3%
Ret/ On Assets - 3 Yr. Avg. 18.4%
Return On Total Capital 0.1%
Ret/ On T. Cap. - 3 Yr. Avg. 16%
Return On Equity 0.7%
Return On Equity - 3 Yr. Avg. -50.9%
Asset Turnover 2.9
Profitability Ratios
Gross Margin 23.7%
Gross Margin - 3 Yr. Avg. 25.9%
EBITDA Margin 3.1%
EBITDA Margin - 3 Yr. Avg. 3.9%
Operating Margin 1.4%
Oper. Margin - 3 Yr. Avg. 2.3%
Pre-Tax Margin 0.1%
Pre-Tax Margin - 3 Yr. Avg. 0.9%
Net Profit Margin 0%
Net Profit Margin - 3 Yr. Avg. 2.8%
Effective Tax Rate 91.7%
Eff/ Tax Rate - 3 Yr. Avg. -87.2%
Payout Ratio 0%

RAD stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the RAD stock intrinsic value calculation we used $32845 million for the last fiscal year's total revenue generated by Rite Aid. The default revenue input number comes from 2017 income statement of Rite Aid. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our RAD stock valuation model: a) initial revenue growth rate of 6.9% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 13.3%, whose default value for RAD is calculated based on our internal credit rating of Rite Aid, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Rite Aid.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of RAD stock the variable cost ratio is equal to 97.6%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for RAD stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.7% for Rite Aid.

Corporate tax rate of 27% is the nominal tax rate for Rite Aid. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the RAD stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for RAD are equal to 9.7%.

Life of production assets of 10 years is the average useful life of capital assets used in Rite Aid operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for RAD is equal to 5.6%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $614 million for Rite Aid - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 1052.36 million for Rite Aid is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Rite Aid at the current share price and the inputted number of shares is $2.4 billion.

RELATED COMPANIES Price Int.Val. Rating
CVS CVS Health 79.25 157.68  str.buy
PETS PetMed Express 46.48 53.47  buy
SFLY Shutterfly 46.68 76.39  str.buy
VSI Vitamin Shoppe 6.05 39.64  str.buy

COMPANY NEWS

▶ Get Back-to-School Ready at Rite Aid   [Aug-02-17 09:50AM  Business Wire]
▶ Seasonal Flu Shots Now Available at Rite Aid   [08:53AM  Business Wire]
▶ ETFs with exposure to Rite Aid Corp. : July 31, 2017   [Jul-31-17 05:03PM  Capital Cube]
▶ 5 Stocks to Avoid at all Costs   [Jul-27-17 03:30PM  Zacks]
▶ Bear of the Day: Rite Aid (RAD)   [06:01AM  Zacks]
▶ Fred's names new exec to C-suite   [Jul-19-17 03:05PM  American City Business Journals]
▶ Why Rite Aid, Novavax, and RH Jumped Today   [Jul-18-17 04:34PM  Motley Fool]
▶ Why I Just Bought Rite Aid Stock   [Jul-16-17 09:02AM  Motley Fool]
▶ Buy Rite Aid Stock Now, and Get Its Stores for Free   [Jul-15-17 10:31AM  Motley Fool]
▶ Rite Aid Corporation (RAD) Stock Is On Life Support   [Jul-11-17 10:51AM  InvestorPlace]
▶ ETFs with exposure to Rite Aid Corp. : July 10, 2017   [Jul-10-17 03:06PM  Capital Cube]
▶ Why Rite Aid Remains A Good Buy   [11:55AM  Forbes]
▶ Walgreens Continues to Be a Wall Street Darling   [Jul-05-17 07:37AM  Market Realist]
▶ The WBA-RAD Deal Drama Has Hurt Both Companies Stocks   [Jul-04-17 10:37AM  Market Realist]
▶ [$$] What Now   [06:42AM  The Wall Street Journal]
▶ What Rite Aid Will Do Now to Survive   [07:41AM  Motley Fool]
▶ Biotech Movers: Paratek, Opko, Endo   [09:22AM  TheStreet.com]
▶ A Somber Look at What's Next for Rite Aid   [08:21AM  Motley Fool]
▶ Walgreens Will Purchase 2,186 Rite Aid Stores   [06:16AM  Market Realist]
▶ [$$] Rite Aid Crashes Into the Bargain Bin   [12:18AM  The Wall Street Journal]
▶ [$$] Walgreens, Rite Aid End $9.4 Billion Merger   [12:16AM  The Wall Street Journal]
▶ Rite Aid reports 1Q loss   [Jun-29-17 10:17PM  Associated Press]
▶ [$$] Walgreens Scores Deal With Purchase of Rite Aid Stores   [06:18PM  The Wall Street Journal]
▶ What Happened in the Stock Market Today   [05:06PM  Motley Fool]
Stock chart of RAD Financial statements of RAD
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.